|
|
 |
| |
|
|
| |
|
|
|
|
Xpention Genetics,
Inc. is a biotechnology company that was
formed to develop both immunological and molecular tests for cancer
detection in animals and humans as well as therapeutic vaccines
and other treatment methods for companion animal
cancers. Xpention, through its wholly-owned subsidiary, has licensed exclusive rights to a specific
genetic marker
called the p65 that has highly specific correlation to numerous
cancers.
|
|
